Anti-NDC1/ NET3/ ™EM48 monoclonal antibody

Anti-NDC1/ NET3/ ™EM48 antibody for FACS & in-vivo assay

Target products collectionGo to NDC1/NDC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0870-Ab-1/ GM-Tg-hg-MP0870-Ab-2Anti-Human NDC1 monoclonal antibodyHuman
GM-Tg-rg-MP0870-Ab-1/ GM-Tg-rg-MP0870-Ab-2Anti-Rat NDC1 monoclonal antibodyRat
GM-Tg-mg-MP0870-Ab-1/ GM-Tg-mg-MP0870-Ab-2Anti-Mouse NDC1 monoclonal antibodyMouse
GM-Tg-cynog-MP0870-Ab-1/ GM-Tg-cynog-MP0870-Ab-2Anti-Cynomolgus/ Rhesus macaque NDC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0870-Ab-1/ GM-Tg-felg-MP0870-Ab-2Anti-Feline NDC1 monoclonal antibodyFeline
GM-Tg-cang-MP0870-Ab-1/ GM-Tg-cang-MP0870-Ab-2Anti-Canine NDC1 monoclonal antibodyCanine
GM-Tg-bovg-MP0870-Ab-1/ GM-Tg-bovg-MP0870-Ab-2Anti-Bovine NDC1 monoclonal antibodyBovine
GM-Tg-equg-MP0870-Ab-1/ GM-Tg-equg-MP0870-Ab-2Anti-Equine NDC1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0870-Ab-1/ GM-Tg-hg-MP0870-Ab-2; GM-Tg-rg-MP0870-Ab-1/ GM-Tg-rg-MP0870-Ab-2;
GM-Tg-mg-MP0870-Ab-1/ GM-Tg-mg-MP0870-Ab-2; GM-Tg-cynog-MP0870-Ab-1/ GM-Tg-cynog-MP0870-Ab-2;
GM-Tg-felg-MP0870-Ab-1/ GM-Tg-felg-MP0870-Ab-2; GM-Tg-cang-MP0870-Ab-1/ GM-Tg-cang-MP0870-Ab-2;
GM-Tg-bovg-MP0870-Ab-1/ GM-Tg-bovg-MP0870-Ab-2; GM-Tg-equg-MP0870-Ab-1/ GM-Tg-equg-MP0870-Ab-2
Products NameAnti-NDC1 monoclonal antibody
Formatmab
Target NameNDC1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NDC1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NDC1/ NET3/ ™EM48 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP001167human NDC1 Lentivirus plasmid
    ORF Viral VectorvGMLP001167human NDC1 Lentivirus particle
    ORF Viral VectorpGMLPm003621mouse Ndc1 Lentivirus plasmid
    ORF Viral VectorvGMLPm003621mouse Ndc1 Lentivirus particle


    Target information

    Target IDGM-MP0870
    Target NameNDC1
    Gene ID55706,72787,362557,703600,100684187,101094524,616114,100050513
    Gene Symbol and Synonyms2810475A17Rik,NDC1,NET3,sks,™EM48
    Uniprot AccessionQ9BTX1,Q6AXN4
    Uniprot Entry NameNDC1_HUMAN,NDC1_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000058804
    Target ClassificationN/A

    The target: NDC1, gene name: NDC1, also named as NET3, ™EM48. A structural constituent of nuclear pore. Involved in nuclear pore complex assembly and nuclear pore localization. Located in actin cytoskeleton; nuclear membrane; and plasma membrane. Part of nuclear pore. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.